Prevalence of the 23 S rRNA A 2058 G Point Mutation and Molecular Subtypes in Treponema pallidum in the United States , 2007 to 2009 The A 2058
暂无分享,去创建一个
[1] J. Fyfe,et al. Molecular Subtyping of Treponema pallidum during a Local Syphilis Epidemic in Men Who Have Sex with Men in Melbourne, Australia , 2012, Journal of Clinical Microbiology.
[2] Stuart Berman,et al. Sexually transmitted diseases treatment guidelines, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[3] P. Zhou,et al. Azithromycin Treatment Failure Among Primary and Secondary Syphilis Patients in Shanghai , 2010, Sexually transmitted diseases.
[4] M. Golden,et al. Enhanced molecular typing of treponema pallidum: geographical distribution of strain types and association with neurosyphilis. , 2010, The Journal of infectious diseases.
[5] H. Zhu,et al. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in Chlamydia trachomatis strains selected in vitro by macrolide passage , 2010, Andrologia.
[6] S. Chisholm,et al. High-Level Azithromycin Resistance Occurs in Neisseria gonorrhoeae as a Result of a Single Point Mutation in the 23S rRNA Genes , 2010, Antimicrobial Agents and Chemotherapy.
[7] F. Behets,et al. A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. , 2010, The Journal of infectious diseases.
[8] I. Martin,et al. Macrolide resistance and molecular types of Treponema pallidum causing primary syphilis in Shanghai, China. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] L. Wallace,et al. Molecular epidemiology of syphilis in Scotland , 2009, Sexually Transmitted Infections.
[10] G. Weinstock,et al. Macrolide treatment failure in a case of secondary syphilis: a novel A2059G mutation in the 23S rRNA gene of Treponema pallidum subsp. pallidum. , 2009, Journal of medical microbiology.
[11] I. Martin,et al. Molecular Characterization of Syphilis in Patients in Canada: Azithromycin Resistance and Detection of Treponema pallidum DNA in Whole-Blood Samples versus Ulcerative Swabs , 2009, Journal of Clinical Microbiology.
[12] J. P. Gomes,et al. Molecular Typing of Treponema pallidum Clinical Strains from Lisbon, Portugal , 2008, Journal of Clinical Microbiology.
[13] D. Palmero,et al. Mycobacterium avium complex infection in HIV/AIDS patients , 2008, Expert review of anti-infective therapy.
[14] M. Siedner,et al. Detection of Azithromycin Resistance in Treponema pallidum by Real-Time PCR , 2007, Antimicrobial Agents and Chemotherapy.
[15] S. Berman,et al. Trends in primary and secondary syphilis among men who have sex with men in the United States. , 2007, American journal of public health.
[16] C. Marra,et al. Antibiotic selection may contribute to increases in macrolide-resistant Treponema pallidum. , 2006, The Journal of infectious diseases.
[17] D. L. Cox,et al. Diagnosis of Gastric Syphilis by Direct Immunofluorescence Staining and Real-Time PCR Testing , 2006, Journal of Clinical Microbiology.
[18] C. Kent,et al. Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] M. Morshed,et al. Determining optimal catheterization rates , 2006, Canadian Medical Association Journal.
[20] S. Groseclose,et al. The Changing Epidemiology of Syphilis , 2005, Sexually transmitted diseases.
[21] M. Hoelscher,et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. , 2005, The New England journal of medicine.
[22] A. Seña,et al. Molecular Subtyping of Treponema pallidum from North and South Carolina , 2005, Journal of Clinical Microbiology.
[23] H. Ohya,et al. Characterization and Molecular Analysis of Macrolide-Resistant Mycoplasma pneumoniae Clinical Isolates Obtained in Japan , 2004, Antimicrobial Agents and Chemotherapy.
[24] J. Klausner,et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. , 2004, The New England journal of medicine.
[25] L. Finelli,et al. Molecular subtyping of Treponema pallidum in an Arizona County with increasing syphilis morbidity: use of specimens from ulcers and blood. , 2001, The Journal of infectious diseases.
[26] M. Morshed,et al. Mass treatment/prophylaxis during an outbreak of infectious syphilis in Vancouver, British Columbia. , 2000, Canada communicable disease report = Releve des maladies transmissibles au Canada.
[27] L. Stamm,et al. A Point Mutation Associated with Bacterial Macrolide Resistance Is Present in Both 23S rRNA Genes of an Erythromycin-ResistantTreponema pallidum Clinical Isolate , 2000, Antimicrobial Agents and Chemotherapy.
[28] E. Hook,et al. Azithromycin Compared with Penicillin G Benzathine for Treatment of Incubating Syphilis , 1999, Annals of Internal Medicine.
[29] S. Morse,et al. Molecular Subtyping of Treponema pallidum Subspecies pallidum , 1998, Sexually transmitted diseases.
[30] J. Stapleton,et al. In vitro assay to demonstrate high-level erythromycin resistance of a clinical isolate of Treponema pallidum , 1988, Antimicrobial Agents and Chemotherapy.